French pharma makes move into haemophilia market.
Dr Fiona Marshall joins MSD from Sosei from Heptares, the UK biotech company she co-founded more than a decade ago, and which was acquired by Sosei in 2015.
Drug likely to cost just under £10,000 per six-monthly injection.
Richard Staines gives his weekly round-up of the biggest stories in digital health.
Public health experts and UK life science leaders are reiterating concerns about Brexit’s threat to the nation’s health.
How are physicians today interacting with pharma and healthcare resources?